USPTO serial 90833462
ESGPHARM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- VERHOSEK, WILLIAM T
- Law office
- TMO LAW OFFICE 114 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ESGPHARM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Diane J. Mason
DIANE J. MASON FAEGRE DRINKER BIDDLE & REATH LLPFOUR EMBARCADERO CENTER, 27TH FLOORSAN FRANCISCO, CA 94111UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom manufacture of pharmaceuticals; custom manufacturing services in the nature of processing of pharmaceutical preparations; custom manufacturing services in the nature of processing of medicinal materials; custom manufacture of biopharmaceuticals; treatment of biopharmaceutical materials; processing of biopharmaceutical materials for others; custom manufacturing services in the nature of processing of biopharmaceutical materials for others; preservation of pharmaceuticals; custom manufacturing services in the nature of processing of medical products; processing of plant material; processing of plant extracts in the nature of separation of extractants; processing of plants to obtain oils from plant material; processing of biomass; prototype fabrication of new products for others; custom manufacturing services in the nature of processing of plant growth promoting preparations; conversion of targeted substrates into targeted chemical preparations by treatment with enzyme systems; custom manufacture of pharmaceuticals using biological organisms in the manufacturing process; custom manufacturing services in the nature of processing of pharmaceutical preparations using biological organisms; custom manufacture of machines and tools for compressing and compacting powders and granules | ACTIVE | — |
| 042 | Pharmaceutical research and development; pharmaceutical drug development services; inspection of pharmaceuticals; consultancy in the fields of pharmaceutical research and development; analysis and evaluation of medical product development; research relating to medicines; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; research and development in the field of plant-based biopharmaceutical production; development of pharmaceutical preparations and medicines; medical research in the field of crude drugs; microbial culture trials; protein analysis for scientific research purposes; industrial analysis and research services in the field of protein analysis; genetic engineering services relating to plants; scientific research relating to genetics of plants; providing laboratory research services in the field of gene expression, namely, cancer biology; laboratory services relating to the production of monoclonal antibodies; genetic engineering services relating to plants for pharmaceuticals; scientific research relating to plant breeding for pharmaceuticals | ACTIVE | — |
| 044 | Consultancy and information services relating to pharmaceutical products; advisory services relating to pharmaceutical products; medical consultancy relating to pharmaceutical and medical products; advisory services relating to pharmaceuticals; providing consultancy and information services relating to biopharmaceutical products; pharmaceutical advice; consultancy and information services provided via the Internet relating to pharmaceutical products; cultivation of plants for use in pharmaceuticals for others; farming services in the field of plants used for pharmaceuticals; cultivation of host plants for plant-based biopharmaceutical production for others; plant seed services, namely, providing data, information and analysis in the field of seed performance for medical purposes; information services relating to flora used in pharmaceuticals and medical treatments; plant nursery services; cultivation of plants for use in the development of biopharmaceuticals for others; provision of gene therapy for medical treatment purposes; provision of genetic information for medical treatment purposes; analysis of human biodata for medical purposes; DNA analysis for medical purposes; genetic testing for medical purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 21, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 21, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 20, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 20, 2021 | NWAP | NEW APPLICATION ENTERED | — |